GlaxoSmithKline's prospective two-monthly two-drug injection to treat HIV w...
FILE PHOTO: The GlaxoSmithKline logo is seen on top of GSK Asia House in Singapore, March 21, 2018. REUTERS/Loriene Perera/File Photo GLOBAL BUSINESS WEEK AHEAD
The long-acting needle-based combination of its drug cabotegravir and Janssen’s treatment rilpivirine met its main goal in the study, which was testing the regimen in adults with HIV-1 whose virus was suppressed. “This is further progress in our efforts to reduce the number of medicines a person living with HIV must take while also reducing the frequency of treatments,” said Kimberly Smith, Head of Research & Development at ViiV.
The HIV-1 category has the most widespread strains of the AIDS-causing virus, which severely affects the body’s immune system.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Here in the South, HIV/AIDS is killing in the shadows like it's 1989. We have to break the stigma | OpinionThe new face of America's HIV/AIDS epidemic is black men in mostly rural Southern states like Alabama. Men like me.
Read more »
More Antibiotics, Higher Odds for Colon Cancer?Taking certain antibiotics -- especially multiple times or for long courses -- may put you at risk for colon cancer, a large new study suggests.
Read more »
California police say hotel worker had arsenal of guns, threatened mass shootingCalifornia police say a mass shooting may have been prevented when a co-worker reported a disgruntled employee had threatened to shoot workers and customers at a hotel.
Read more »
https://time.comBreaking news and analysis from TIME.com. Politics, world news, photos, video, tech reviews, health, science and entertainment news.
Read more »